首页> 外文OA文献 >Cost and Clinical Analysis of Autologous Hematopoietic Stem Cell Mobilization with G-CSF and Plerixafor Compared to G-CSF and Cyclophosphamide

【2h】

Cost and Clinical Analysis of Autologous Hematopoietic Stem Cell Mobilization with G-CSF and Plerixafor Compared to G-CSF and Cyclophosphamide

机译：与G-CSF和环磷酰胺相比，G-CSF和Plerixafor自体造血干细胞动员的成本和临床分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Shaughnessy Paul; Islas-Ohlmayer Miguel; Murphy Julie; Hougham Maureen; MacPherson Jill; Winkler Kurt; Silva Matthew; Steinberg Michael; Matous Jeffrey; Selvey Sheryl; Maris Michael; McSweeney Peter A.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 单一剂量G-CSF用于异基因外周血造血干细胞动员和移植后造血恢复的临床研究 [J] . 田红, 周淑芸, 广东省干细胞移植协作组癌症（英文版） . 2003,第012期
2. Cost and clinical analysis of autologous hematopoietic stem cell mobilization with G-CSF and plerixafor compared to G-CSF and cyclophosphamide. [J] . Shaughnessy P, Islas Ohlmayer M, Murphy J, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2011,第5期

机译：与G-CSF和环磷酰胺相比，使用G-CSF和plerixafor自体造血干细胞动员的成本和临床分析。
3. Cost and Outcome Analysis of Autologous Peripheral Blood Stem Cell Mobilization with Plerixafor and G-CSF vs. Cyclophosphamide and G-CSF in Patients with Multiple Myeloma: A Reassessment in View of Increased Costs of Cyclophosphamide [J] . Chen Christopher Chun Man, Campen Christopher, McBride Ali, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：多发性骨髓瘤患者使用Plerixafor和G-CSF与Cyclophosphamide和G-CSF进行自体外周血干细胞动员的成本和结果分析：鉴于环磷酰胺成本增加，需要重新评估
4. Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy-era with plerixafor and G-CSF has superior efficacy but significantly higher costs compared to mobilization with low-dose cyclophosphamide and G-CSF [J] . ChaudharyL., AwanF., CumpstonA., Journal of clinical apheresis. . 2013,第5期

机译：在多发性骨髓瘤患者中，外周血干细胞动员在新的治疗时代中使用培来沙福和G-CSF进行治疗，与低剂量环磷酰胺和G-CSF进行动员相比具有更高的疗效，但成本却更高
5. Alterations of Frequency of Hematopoietic Precursors in Mice Subjected to Multiple Courses of Low-Dose G-CSF Injections [C] . Irina N. Nifont, Daria A. Svinareva, Joseph L. Chertkov, NATO Advanced Research Workshop on Stem Cells and their Potential for Clinical Application . 2008

机译：对小鼠造血前体频率的改变对低剂量G-CSF注射课程进行多种课程
6. Systemic levels of G-CSF and IL-6 determine the angiogenic potential of bone marrow resident monocytes. [D] . Gregory, Alyssa Diane. 2009

机译：G-CSF和IL-6的全身水平决定了骨髓驻留单核细胞的血管生成潜力。
7. Safety and Efficacy of Upfront Plerixafor + G-CSF vs. Placebo + G-CSF for Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients ≥60 and 60 Years of Age with Non-Hodgkin’s Lymphoma or Multiple Myeloma [O] . Ivana N. Micallef, Patrick J. Stiff, Edward A. Stadtmauer, -1

机译：60岁以上和60岁以下非霍奇金淋巴瘤或多发性骨髓瘤患者中前者Plerixafor + G-CSF与安慰剂+ G-CSF调动CD34 +造血祖细胞的安全性和有效性
8. Cost and Outcome Analysis of Autologous Peripheral Blood Stem Cell Mobilization with Plerixafor and G-CSF vs. Cyclophosphamide and G-CSF in Patients with Multiple Myeloma: A Reassessment in View of Increased Costs of Cyclophosphamide [O] . Christopher Chun Man Chen, Christopher Campen, Ali McBride, 2016

机译：具有多骨瘤患者的基磷脂和G-CSF与G-CSF与G-CSF与环磷酰胺和G-CSF的成本和结果分析：鉴于环磷酰胺成本的重新评估

Cost and Clinical Analysis of Autologous Hematopoietic Stem Cell Mobilization with G-CSF and Plerixafor Compared to G-CSF and Cyclophosphamide

著录项

引文网络

相似文献

相关主题

期刊订阅